Literature DB >> 7693289

Muscarinic excitatory and inhibitory mechanisms involved in afferent fibre-evoked depolarization of motoneurones in the neonatal rat spinal cord.

T Kurihara1, H Suzuki, M Yanagisawa, K Yoshioka.   

Abstract

1. The involvement of acetylcholine and muscarinic receptors in spinal synaptic responses evoked by electrical and noxious sensory stimuli was investigated in the neonatal rat spinal cord in vitro. 2. Potentials were recorded extracellularly from a ventral root (L3-L5) of the isolated spinal cord, spinal cord-cutaneous nerve, and spinal cord-skin preparations of 1- to 4-day-old rats. Spinal reflexes were elicited by electrical stimulation of the ipsilateral dorsal root or the cutaneous saphenous nerve, or by noxious skin stimulation. 3. Single shock stimulation of supramaximum intensity of a dorsal root induced a mono-synaptic reflex in the corresponding ventral root. Bath-application of the muscarinic agonists, muscarine (0.3-30 microM) and (+)-cis-dioxolane (0.1-100 microM), produced an inhibition of the mono-synaptic reflex and a depolarization of motoneurones. Other muscarinic agonists, arecoline (10 nM-10 microM) and oxotremorine (10 nM-1 microM), inhibited the mono-synaptic reflex with little or no depolarization of motoneurones. Repetitive stimulation of the saphenous nerve at C-fibre strength induced a slow depolarizing response lasting about 30 s of the L3 ventral root. This slow ventral root potential (VRP) was also inhibited by arecoline (10 nM-10 microM) and oxotremorine (10 nM-1 microM). 4. In the spinal cord-saphenous nerve-skin preparation, a slow VRP was evoked by application of capsaicin (0.5 microM), bradykinin (3 microM), or noxious heat (47 degrees C) to skin. This slow VRP was depressed by the muscarinic agonists, arecoline (3 microM) and oxotremorine (1 microM). 5. Of the (+)-cis-dioxolane-induced inhibition of mono-synaptic reflex and motoneurone depolarization, the M2 antagonists, AF-DX 116 (0.1-1 microM) and methoctramine (100-300 nM), preferentially blocked the former response, whereas the M3 antagonists, 4-DAMP (3-10 nM) and p-F-HHSiD (0.3-3 microM), preferentially blocked the latter response. AF-DX 116 (0.1-1 microM) and methoctramine (100-300 nM) also effectively antagonized the arecoline- and oxotremorine-induced inhibition of the slow VRP. The pA2 values of AF-DX 116 and methoctramine against the arecoline-induced inhibition of the mono-synaptic reflex were both 6.79, and that of 4-DAMP against the (+)-cis-dioxolane-induced motoneurone depolarization was 8.16. 6. In the spinal cord-cutaneous nerve preparation, the saphenous nerve-evoked slow VRP was augmented by the anticholinesterase, edrophonium (5 microM). AF-DX 116 (1 microM) and methoctramine (100 nM) also potentiated the slow VRP, whereas 4-DAMP (10 nM) depressed the response. 4-DAMP(5-10 nM) depressed the capsaicin-induced slow VRP in the spinal cord-skin preparation.7. Oxotremorine (0.3 microM) and arecoline (1 AM) markedly depressed the depolarization of motoneurones evoked by application of capsaicin (3 9AM) to the spinal cord, whereas they depressed only slightly the depolarization induced by substance P (10 nM).8. The present study suggests that both excitatory (via M3-type receptors) and inhibitory (via M2-type receptors) muscarinic mechanisms are involved in afferent fibre-evoked nociceptive transmissions in the neonatal rat spinal cord.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7693289      PMCID: PMC2175966          DOI: 10.1111/j.1476-5381.1993.tb13772.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist.

Authors:  A Giachetti; R Micheletti; E Montagna
Journal:  Life Sci       Date:  1986-05-05       Impact factor: 5.037

2.  Antinociception opioids and the cholinergic system.

Authors:  P G Green; I Kitchen
Journal:  Prog Neurobiol       Date:  1986       Impact factor: 11.685

3.  Topography of choline acetyltransferase immunoreactive neurons and fibers in the rat spinal cord.

Authors:  L F Borges; S D Iversen
Journal:  Brain Res       Date:  1986-01-01       Impact factor: 3.252

4.  Antagonist discrimination between ganglionic and ileal muscarinic receptors.

Authors:  D A Brown; A Forward; S Marsh
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

5.  A substance P antagonist inhibits a slow reflex response in the spinal cord of the newborn rat.

Authors:  M Yanagisawa; M Otsuka; S Konishi; H Akagi; K Folkers; S Rosell
Journal:  Acta Physiol Scand       Date:  1982-09

6.  The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord.

Authors:  H Akagi; S Konishi; M Otsuka; M Yanagisawa
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

7.  The morphology and distribution of neurons containing choline acetyltransferase in the adult rat spinal cord: an immunocytochemical study.

Authors:  R P Barber; P E Phelps; C R Houser; G D Crawford; P M Salvaterra; J E Vaughn
Journal:  J Comp Neurol       Date:  1984-11-01       Impact factor: 3.215

8.  The relevance of cholinergic transmission at the spinal level to opiate effectiveness.

Authors:  R Dirksen; G M Nijhuis
Journal:  Eur J Pharmacol       Date:  1983-07-22       Impact factor: 4.432

9.  Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat.

Authors:  T L Yaksh; R Dirksen; G J Harty
Journal:  Eur J Pharmacol       Date:  1985-10-29       Impact factor: 4.432

10.  Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitro.

Authors:  R U Clague; R M Eglen; A C Strachan; R L Whiting
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

View more
  10 in total

1.  Cholinergic control of excitability of spinal motoneurones in the salamander.

Authors:  Stéphanie Chevallier; Frédéric Nagy; Jean-Marie Cabelguen
Journal:  J Physiol       Date:  2005-11-24       Impact factor: 5.182

Review 2.  Synaptic control of motoneuronal excitability.

Authors:  J C Rekling; G D Funk; D A Bayliss; X W Dong; J L Feldman
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

3.  Upregulation of casein kinase 1epsilon in dorsal root ganglia and spinal cord after mouse spinal nerve injury contributes to neuropathic pain.

Authors:  Eri Sakurai; Takashi Kurihara; Kasumi Kouchi; Hironao Saegusa; Shuqin Zong; Tsutomu Tanabe
Journal:  Mol Pain       Date:  2009-12-18       Impact factor: 3.395

4.  The excitatory and inhibitory modulation of primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord exerted by nitric oxide.

Authors:  T Kurihara; K Yoshioka
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Electrophysiological and pharmacological properties of locomotor activity-related neurons in cfos-EGFP mice.

Authors:  Yue Dai; Kevin P Carlin; Zongming Li; Douglas G McMahon; Robert M Brownstone; Larry M Jordan
Journal:  J Neurophysiol       Date:  2009-09-30       Impact factor: 2.714

6.  Cellular and synaptic actions of acetylcholine in the lamprey spinal cord.

Authors:  Katharina A Quinlan; James T Buchanan
Journal:  J Neurophysiol       Date:  2008-06-11       Impact factor: 2.714

7.  Cholinergic partition cells and lamina x neurons induce a muscarinic-dependent short-term potentiation of commissural glutamatergic inputs in lumbar motoneurons.

Authors:  Sandrine S Bertrand; Jean-René Cazalets
Journal:  Front Neural Circuits       Date:  2011-11-04       Impact factor: 3.492

8.  Balanced cholinergic modulation of spinal locomotor circuits via M2 and M3 muscarinic receptors.

Authors:  Filipe Nascimento; Lennart R B Spindler; Gareth B Miles
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

Review 9.  Acetylcholine and spinal locomotor networks: The insider.

Authors:  Théo Mille; Camille Quilgars; Jean-René Cazalets; Sandrine S Bertrand
Journal:  Physiol Rep       Date:  2021-02

10.  Spinal cholinergic interneurons differentially control motoneuron excitability and alter the locomotor network operational range.

Authors:  Maria Bertuzzi; Konstantinos Ampatzis
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.